Journal of peptide science : an official publication of the European Peptide SocietyHumansDiabetes MellitusType 2Glucagon-Like Peptide 1Gastric Inhibitory Polypeptide
Emerging Therapies in Metabolic Health: A Comprehensive Review of GLP-1, GIP, and Glucagon Agonists.
Mohammed Shareef Khan, Utkarsh Bhutani, Hariharan Venugopal, Anuj Kumar Saini, Venkat Ramana Naidu, Sivacharan Kollipara
Published: 202610.1002/psc.70083
Abstract
Incretin-based therapies have become central to type 2 diabetes (T2D) management, offering benefits beyond glycemic control, including weight reduction, cardiovascular protection, and emerging roles in renal and neurological health. This review addre…
Preview only. Read the full abstract at the source